皮脂腺肿瘤:不止于皮肤表面
一例77岁男性在2006至2017年间出现多种皮肤肿瘤,包括左上背部「汗腺癌」、左肩皮脂腺瘤及2017年中上背部皮脂腺癌;免疫组化显示肿瘤细胞MSH2表达缺失,外周血分子遗传学分析发现MSH2基因第7外显子杂合性缺失,多名家族成员检测到MSH2突变并接受遗传咨询,最终诊断为Muir-Torre综合征(MTS)。
要点
- 多种皮脂腺肿瘤患者应警惕Muir-Torre综合征(MTS)。
- 肿瘤组织MSH2表达缺失及外周血MSH2基因突变支持MTS诊断。
- 确诊MTS后家族成员应行基因检测与遗传咨询。
核心结论
- 该患者最终诊断为Muir-Torre综合征(MTS)。
研究设计与样本
- 病例报告:一例77岁男性,2006至2017年间于皮肤癌中心就诊并出现多种皮肤肿瘤。
主要发现
- 组织病理学显示2006年左上背部「汗腺癌」、2011年左肩皮脂腺瘤、2017年中上背部皮脂腺癌(表现为缓慢增大、无症状结节)。
- 既往史包括1988年结直肠癌根治性切除。
- 最新皮脂腺癌免疫组化显示肿瘤细胞细胞角蛋白5/6、细胞角蛋白7、分化簇抗原10、脂滴包被蛋白、雄激素受体、上皮膜抗原、KI67抗原、MLH1及PMS2阳性,而Gross囊性疾病液体蛋白15、前列腺特异性抗原、碳水化合物抗原19/9、CDX2蛋白、肝细胞特异性抗原、癌胚抗原、分化簇抗原117及细胞角蛋白19阴性。
- 进一步免疫组化显示MLH1、MSH6及PMS2核表达阳性,而MSH2在几乎所有肿瘤细胞中表达缺失。
- PET/CT及结肠镜检查未发现病理学异常;外周血分子遗传学分析显示MSH2基因第7外显子杂合性缺失,随后多名家族成员检测到MSH2突变并接受遗传咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: CLINICAL PRESENTATION: A 77-year-old man presented to our skin cancer centre with various cutaneous tumours occurring in 2006-2017. Histopathology showed a 'hidradenocarcinoma' on the left upper back (2006) and a sebaceous adenoma (figure 1) on the left shoulder (2011). In 2017, he developed a sebaceous carcinoma on the middle upper back, which manifested as a slowly enlarging, asymptomatic nodule. Medical history was significant for curative resection of colorectal cancer in 1988.gutjnl;67/11/1957/F1F1F1Figure 1Clinical appearance of the sebaceous adenoma on the patient's left shoulder in 2011.The most recent lesion was subjected to extensive immunohistochemical assessment. The neoplastic cells were positive for cytokeratin 5/6, cytokeratin 7, cluster of differentiation antigen 10, adipophilin, androgen receptor, epithelial membrane antigen, KI67 antigen, MLH1 and PMS2, but stained negative for gross cystic disease fluid protein 15, prostate-specific antigen, carbohydrate antigen 19/9, CDX2 protein, hepatocyte-specific antigen, carcinoembryonic antigen, cluster of differentiation antigen 117 and cytokeratin 19. Given the variety of histological manifestations of the patient's skin neoplasms, further studies were performed. They revealed positive nuclear expression signals for MLH1, MSH6 and PMS2, whereas MSH2 expression was absent in almost all tumour cells (figure 2). Positron emission tomography (PET)/CT and colonoscopy did not detect any pathological findings. However, molecular genetic analysis of peripheral blood showed a heterozygous deletion of exon 7 of the MSH2 gene. Subsequently, several family members tested positive for MSH2 mutations and underwent genetic counselling.gutjnl;67/11/1957/F2F2F2Figure 2(A-D) Histopathological images of the patient's most recent lesion (diaminobenzidine, original magnification, ×100). The tumour cells demonstrated strong nuclear positivity for MLH1 (A) and PMS2 (B), but were essentially negative for MSH6 (C) and MSH2 (D). QUESTION: What is your diagnosis? DIAGNOSIS: Muir-Torre syndrome (MTS).
引用
- Jockenhöfer F, Schimming TT, Schaller J, et al. Sebaceous tumours: more than skin deep. Gut. 2017. PMID: 29247065. doi:10.1136/gutjnl-2017-315472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。